Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 27.18
+0.27 (1.00%)
Jan 23, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | 215.41 | -20.16 | 16.78 | 52.71 | 132.87 | 150.16 | Upgrade |
Depreciation & Amortization | 113.13 | 113.13 | 120.39 | 62.57 | 28.54 | 19.08 | Upgrade |
Other Amortization | 0.91 | 0.91 | 0.63 | 0.12 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | -0.01 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 0.21 | 0.21 | 0.67 | 0.51 | 0.06 | 6.63 | Upgrade |
Loss (Gain) From Sale of Investments | 15.45 | 15.45 | -25.37 | -7.01 | -4.4 | -0.85 | Upgrade |
Provision & Write-off of Bad Debts | -1.68 | -1.68 | 24.94 | 10.77 | -7.07 | - | Upgrade |
Other Operating Activities | -15.62 | 45.54 | 31.08 | 9.05 | 6.31 | 2.51 | Upgrade |
Change in Accounts Receivable | -210.12 | -210.12 | -109.82 | 14.44 | 21.69 | -195.02 | Upgrade |
Change in Inventory | -20.83 | -20.83 | -28.06 | 30.42 | -105.92 | -55.82 | Upgrade |
Change in Accounts Payable | 136.38 | 136.38 | 71.98 | -71.04 | 67.53 | 119.61 | Upgrade |
Change in Other Net Operating Assets | 4.26 | 4.26 | - | -0.94 | 18.31 | 1.16 | Upgrade |
Operating Cash Flow | 217.94 | 43.53 | 92.92 | 96.68 | 155.72 | 48.35 | Upgrade |
Operating Cash Flow Growth | 407.19% | -53.15% | -3.89% | -37.91% | 222.07% | -54.06% | Upgrade |
Capital Expenditures | -96.47 | -194.43 | -184.31 | -428.87 | -600.12 | -230.84 | Upgrade |
Sale of Property, Plant & Equipment | 0.71 | 0.42 | - | 0.07 | 0.1 | 0.19 | Upgrade |
Investment in Securities | -29.01 | 84 | 69.85 | -330 | 410 | -440 | Upgrade |
Other Investing Activities | 5.75 | 8.19 | 14.16 | 9.25 | 4.87 | 0.22 | Upgrade |
Investing Cash Flow | -120.17 | -101.81 | -100.3 | -749.54 | -185.15 | -670.44 | Upgrade |
Short-Term Debt Issued | - | 56.59 | 53.92 | 221.37 | - | - | Upgrade |
Long-Term Debt Issued | - | 480 | 210.85 | - | 135.21 | 114 | Upgrade |
Total Debt Issued | 366.59 | 536.59 | 264.77 | 221.37 | 135.21 | 114 | Upgrade |
Long-Term Debt Repaid | - | -479.56 | -244.3 | -139.8 | -73.52 | -130.58 | Upgrade |
Total Debt Repaid | -386.01 | -479.56 | -244.3 | -139.8 | -73.52 | -130.58 | Upgrade |
Net Debt Issued (Repaid) | -19.42 | 57.04 | 20.47 | 81.57 | 61.69 | -16.58 | Upgrade |
Issuance of Common Stock | 16.35 | 16.35 | - | - | 700.96 | 867.63 | Upgrade |
Repurchase of Common Stock | -3.26 | -3.26 | -3.31 | -53.68 | - | - | Upgrade |
Common Dividends Paid | -56.72 | -59.16 | -58.63 | -62.48 | -47.94 | -5.99 | Upgrade |
Other Financing Activities | -20.68 | 3 | - | -0.01 | -4.63 | -19.33 | Upgrade |
Financing Cash Flow | -83.73 | 13.98 | -41.48 | -34.6 | 710.09 | 825.72 | Upgrade |
Foreign Exchange Rate Adjustments | -0.57 | -0.61 | -0.23 | -0.07 | -0.03 | -0.04 | Upgrade |
Net Cash Flow | 13.48 | -44.92 | -49.09 | -687.53 | 680.63 | 203.6 | Upgrade |
Free Cash Flow | 121.46 | -150.89 | -91.39 | -332.18 | -444.4 | -182.49 | Upgrade |
Free Cash Flow Margin | 7.29% | -12.57% | -8.96% | -32.48% | -44.61% | -23.47% | Upgrade |
Free Cash Flow Per Share | 0.67 | -0.91 | -0.55 | -2.01 | -2.68 | -1.24 | Upgrade |
Cash Income Tax Paid | 66.35 | 40.27 | 41.25 | 0.09 | 1.6 | 41.09 | Upgrade |
Levered Free Cash Flow | 62.2 | -159.5 | -223.53 | -217.62 | -467.49 | -209.64 | Upgrade |
Unlevered Free Cash Flow | 75.07 | -132.83 | -205.9 | -206.14 | -465.69 | -208.2 | Upgrade |
Change in Working Capital | -109.88 | -109.88 | -76.2 | -32.04 | -0.58 | -129.18 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.